Hogan Lovells Our thinking banner

Our thinking

Discover insights, analysis, and thought leadership that are vital for change. Success today requires actionable insights, perspectives that cut through complexity, and tools to navigate the evolving needs of your sector shaping a stronger tomorrow.

Insights and Analysis

FDA endorses prior knowledge use in gene therapy development

09 June 2026

Insights and Analysis

European Commission publishes long-awaited guidelines on high-risk AI systems

27 May 2026

Insights and Analysis

AI-washing – when AI hype becomes a litigation risk

26 May 2026

Insights and Analysis

Overview of the CNIL’s deliberations in 2025: when sanctions precede recommendations

18 May 2026

Insights and Analysis

Public Company Conversations Podcast Episode 3

14 May 2026

News

FDA AI tool Elsa 4.0 and HALO unveiled

08 May 2026

News

FDA draft guidance operationalizes animal testing phaseout

30 April 2026

News

Polling, history point to Democratic takeover of House and possibly Senate – clients should prepare now

22 April 2026

News

FCA consults on Perimeter Guidance for the UK’s new cryptoassets regime

20 April 2026

Insights and Analysis

Integrating nature into UK corporate reporting – how should businesses respond to the IPBES business and biodiversity assessment and recent UK national security assessment?

15 April 2026

News

AI in defence: When supplier guardrails meet operational reality

02 April 2026

Insights and Analysis

"Emerging tech" and why it is different

01 April 2026

Load more

Digital Client Solutions

Empowering you to lead change through our digital solutions.